Front Row Advisors’s Insys Therapeutics, Inc. INSY Stock Holding History

Front Row Advisors’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-60	Closed	–	–	1084
2019 Q4	$0	Hold	60	–	–	﹤0.01%	970
2019 Q3	$0	Hold	60	–	–	﹤0.01%	1061
2019 Q2	$0	Hold	60	–	–	﹤0.01%	1096
2019 Q1	$0	Buy	+60	New	+$284	﹤0.01%	1124

Front Row Advisors's INSY Position: Q1 2020 in Review

Front Row Advisors sold out of Insys Therapeutics, Inc. (INSY) in Q1 2020, closing a stake of 60 shares.

Front Row Advisors first reported a position in INSY in Q1 2019 and held it in 4 quarters. The position peaked at $0 in Q4 2019. 1 fund tracked by Wall St. Rank holds INSY as of Q1 2020.

Front Row Advisors reported no remaining Insys Therapeutics, Inc. position as of Q1 2020 after selling out during the quarter.
Front Row Advisors sold 60 Insys Therapeutics, Inc. shares in Q1 2020.
Front Row Advisors first reported a position in Insys Therapeutics, Inc. in Q1 2019 and held it in 4 quarters.
Front Row Advisors's Insys Therapeutics, Inc. position peaked at $0 in Q4 2019.
1 fund tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q1 2020.

Based on Front Row Advisors's 13F filing for Q1 2020, filed 8 May 2020.